ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
66 hedge funds and large institutions have $23.7M invested in Zynerba Pharmaceuticals, Inc in 2018 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
67% less call options, than puts
Call options by funds: $1.29M | Put options by funds: $3.96M
Holders
66
Holding in Top 10
–
Calls
$1.29M
Puts
$3.96M
Top Buyers
| 1 | +$1.7M | |
| 2 | +$1.02M | |
| 3 | +$612K | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$519K |
| 5 |
BlackRock
New York
|
+$490K |
Top Sellers
| 1 | -$744K | |
| 2 | -$576K | |
| 3 | -$533K | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$493K |
| 5 |
Morgan Stanley
New York
|
-$421K |